感染症と病理学のジャーナル

抽象的な

Emerging Therapies in Lower Respiratory Tract Infection Management

Philipp Woodhead

Lower respiratory tract infections (LRTIs) pose a significant global health burden, necessitating innovative approaches to management. This article explores the landscape of emerging therapies in LRTI management, highlighting the potential of phage therapy, monoclonal antibodies, host-directed therapies, nanotechnology, immunomodulatory agents, CRISPR-Cas9 technology, mRNA vaccines, and microbiome-based interventions. These promising therapies offer new avenues to combat drug-resistant pathogens, enhance the immune response, and revolutionize the treatment of LRTIs, ultimately improving patient outcomes.